Mucormycosis is a rare and life-threatening fungal infection of the Mucorales order occurring mainly in immunosuppressed patients. The most common forms are rhinocerebral but pulmonary or disseminated forms may occur. We report the case of a 61-year-old patient in whom pulmonary mucormycosis was diagnosed during his first-ever episode of diabetic ketoacidosis. While receiving liposomal amphotericin B, a sinusal aspergillosis due to Aspergillus fumigatus occurred. Evolution was slowly favorable under antifungal tritherapy by liposomal amphotericin B, posaconazole and caspofungin.
Keywords: BAL, Bronchoalveolar Lavage; Bronchial obstruction; Diabetic ketoacidosis; Fungal infection; GVH, raft Versus Host disease; PCR, Polymerase Chain Reaction; Pulmonary mucormycosis; Sinusal aspergillosis.